What is Dieulafoy's lesion and what is the recommended acute management?

Dieulafoy's Lesion: Definition and Acute Management

For acute bleeding from a Dieulafoy's lesion, use mechanical hemostasis with endoscopic band ligation or through-the-scope clips as first-line therapy, or alternatively contact thermocoagulation or sclerosant injection—but avoid epinephrine injection alone. 1

What is a Dieulafoy's Lesion?

A Dieulafoy's lesion is an abnormally dilated submucosal artery (typically 1-3mm in diameter) that erodes through the overlying mucosa without any primary ulceration. 2 This vascular abnormality consists of a large caliber, persistently tortuous submucosal artery with only a small mucosal defect. 3

Key Clinical Features:

• Location: Most commonly found in the proximal stomach within 6 cm of the gastroesophageal junction (though can occur anywhere in the GI tract) 2
• Incidence: Accounts for 1-3.5% of acute upper GI bleeding cases 2, 4
• Demographics: More common in males, typically presenting in the 5th-6th decade of life 5
• Mortality: Historically 23-79%, now reduced to 8-8.6% with modern endoscopic techniques 2, 4

Acute Management Algorithm

Step 1: Initial Resuscitation

• Hemodynamic stabilization is critical—these lesions cause arterial bleeding and can rapidly lead to hypovolemic shock 6
• Transfuse packed red blood cells for hemoglobin <80 g/L (or higher threshold if cardiovascular disease present) 7
• Administer crystalloids, blood products (PRBCs, FFP, platelets), and vasopressors as needed to maintain perfusion 6

Step 2: Early Endoscopy

• Perform endoscopy within 24 hours of presentation (ideally within 12 hours for improved diagnostic accuracy) 7, 2
• Diagnostic challenge: The lesion may be difficult to identify—appears as a pigmented protuberance without ulceration, but can be obscured by active bleeding or small size 2
• Multiple endoscopies may be required (6% need ≥3 procedures for diagnosis) 4

Step 3: Endoscopic Hemostatic Therapy

The 2025 Canadian Association of Gastroenterology guidelines provide the most current evidence-based approach: 1

Preferred first-line options (in order):

1. Mechanical modalities:

   • Endoscopic band ligation
   • Through-the-scope clips

2. Contact thermocoagulation

3. Sclerosant injection

Critical caveat: Do NOT use epinephrine injection alone—it provides suboptimal efficacy and must be combined with another method if used at all 1, 7

Why Mechanical Methods Are Superior:

• Combination therapy is superior to monotherapy with lower rebleeding rates 3
• Mechanical therapies (clips, band ligation) are more effective than thermal or injection methods alone 3
• Initial hemostasis success rates reach 75-100% with endoscopic therapy 3, 4
• Rebleeding rates: 8-10% with appropriate endoscopic treatment 8, 3

Step 4: Rescue Therapies for Endoscopic Failure

If conventional endoscopic therapy fails or is unavailable:

• TC-325 (Hemospray) as temporizing therapy 7
• Angiographic embolization as valuable alternative 2, 4
• Surgical intervention reserved for persistent bleeding despite endoscopic/angiographic attempts 2, 3

Common Pitfalls to Avoid

1. Missing the diagnosis: The lesion may not be visible during initial endoscopy if not actively bleeding—maintain high suspicion and repeat endoscopy if clinical picture suggests Dieulafoy's 2

2. Using epinephrine alone: This is explicitly discouraged by current guidelines—always combine with mechanical or thermal therapy 1, 7

3. Delaying endoscopy: Early endoscopy (within 12 hours) significantly improves diagnostic accuracy 2

4. Inadequate resuscitation: These are arterial bleeds requiring aggressive hemodynamic support with blood products, not just crystalloids 6

5. Medication considerations: Be aware of risk factors including NSAIDs and SSRIs, which can precipitate bleeding 9

Post-Procedure Management

• Proton pump inhibitor therapy 9
• Monitor for rebleeding (occurs in 8-10% of cases) 8, 3
• Multidisciplinary approach involving gastroenterology, interventional radiology, and surgery when needed 2
• Contraindicate NSAIDs in future 9

The dramatic reduction in mortality from 80% to 8.6% reflects advances in endoscopic techniques, making therapeutic endoscopy the definitive first-line treatment for this once-lethal condition. 3, 4